Cogent Biosciences | ARS:年度报告
04/24 04:41
Cogent Biosciences | DEFA14A:其他
04/24 04:38
Cogent Biosciences | DEF 14A:股东委托书决议
04/24 04:38
Cogent Biosciences | PRE 14A:并购重组委托声明
04/13 04:36
Cogent Biosciences | EFFECT:其他
04/11 18:04
Cogent Biosciences | 4:持股变动声明-董事 Ferrante Karen Jean
04/03 06:25
Cogent Biosciences | SC 13D/A:超过5%持股股东披露文件(修正)-Fairmount Funds Management LLC(9.90%),Fairmount Healthcare Fund II GP LLC(9.90%)等
04/02 06:33
Cogent Biosciences | 4:持股变动声明-董事 Fairmount Funds Management LLC
04/02 06:23
Cogent Biosciences | S-3:特定交易注册声明
03/30 04:14
Cogent Biosciences | SC 13D/A:超过5%持股股东披露文件(修正)-Fairmount Funds Management LLC(9.90%),Fairmount Healthcare Fund II GP LLC(9.90%)等
03/28 04:41
Cogent Biosciences | 8-K:重大事件
03/22 20:36
Cogent Biosciences | S-8:员工福利计划证券登记
02/27 05:37
Cogent Biosciences | 10-K:年度报表
02/26 22:15
Cogent Biosciences | 8-K:Cogent Biosciences报告了最近的业务亮点以及2023年第四季度和全年财务业绩
02/26 21:35
Cogent Biosciences | SC 13D/A:超过5%持股股东披露文件(修正)-Fairmount Funds Management LLC(18.89%),Fairmount Healthcare Fund II GP LLC(15.99%)等
02/17 07:57
Cogent Biosciences | 4:持股变动声明-股东 Fairmount Funds Management LLC
02/17 07:47
Cogent Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-Venrock Healthcare Capital Partners II, L.P.(9.99%),VHCP Co-Investment Holdings II, LLC(9.99%)等
02/15 09:38
Cogent Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-Commodore Capital LP(7.1%),Commodore Capital Master LP(7.1%)
02/15 07:08
Cogent Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(0%),Peter Kolchinsky(0%)等
02/15 06:32
Cogent Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-Steven A. Cohen(6.1%),Point72 Asset Management, L.P.(6.0%)等
02/15 05:20
暂无数据
暂无数据